Search
for
Sort by
Research 211–240 of 1000+
- Андрогенетическая алопеция: патогенетические механизмы и подходы к лечению
- Polycystic ovary syndrome: a common reproductive syndrome with long-term metabolic consequences
- Genetics and Epigenetics of Polycystic Ovary Syndrome
- Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
- Female pattern hair loss: current treatment concepts.
- Functional Food Nutrients, Redox Resilience Signaling and Neurosteroids for Brain Health
- Female pattern hair loss: A retrospective study in a tertiary referral center
- Deciphering the Role of Androgen in the Dermatologic Manifestations of Polycystic Ovary Syndrome Patients: A State-of-the-Art Review
- Update on Melasma—Part I: Pathogenesis
- Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women
- Polycystic Ovary Syndrome and Oxidative Stress—From Bench to Bedside
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Endocrine Functions of the Testes
- A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact
- The Effect of Drugs on Hair
- A Case of Ovarian Hyperthecosis in a Postmenopausal Woman
- Pattern of body fat distribution in patients of PCOS using DEXA-based indices
- Androgenetic Alopecia: Clinical Aspects and Treatment
- Ovarian Stromal Hyperthecosis and Hyperandrogenemia Refractory to Hormonal Suppression
- [Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author’s transl)].
- [Proliferation behavior of the anagen hair bulb in androgenetic alopecia before and after local administration of 17 alpha- propylmesterolone–DNA flow cytophotometry studies].
- Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness
- Myrtus communis Leaf Extract Modulates IL-1α and VEGF Gene Expressions in HaCaT Cells: Probable Implications for Its Beneficial Effects in Hair Loss and Wound Healing
- The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study
- Identification of Potential Cytochrome p450c 17 Alpha Inhibitors for the Treatment of PCOS via Scaffold Hopping and Fragment-Based De-Novo Drug Design
- 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
- Crystal Structure of 3-Oxo-4-Aza-5-Alpha-Androstone-17 β-Tert-Butyl Carboxamide with an O···H–(C, N) Acceptor Four-Center Hydrogen Bond
- Crystal Structure and Synthesis of 17.ALPHA.-Acetoxy-6,7-epoxypregn-4-ene-3,20-dione
- Crystal Structure and Synthesis of 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens